Assessing Prognosis in Uveal Melanoma

Area of Science:

• Ophthalmology
• Oncology
• Genetics

Background:

• Uveal melanoma is the most common adult intraocular malignancy.
• High risk of metastasis, often unresponsive to systemic therapy.
• Need for prognostic indicators to identify at-risk patients.

Purpose of the Study:

• Describe advances in uveal melanoma prognostic testing.
• Evaluate the impact of these advances on patient management.

Main Methods:

• Review of relevant, peer-reviewed scientific literature.
• Analysis of prognostic testing methodologies for uveal melanoma.

Main Results:

• Demographic, clinical, and histopathological features are insufficient for predicting metastasis.
• Cytogenetic and transcriptomic features predict metastatic risk.
• Gene expression profiling and chromosomal analysis offer prognostic value.
• Discovery of driver mutations for targeted therapy.

Conclusions:

• Assay validation and quality control are crucial for test reliability.
• Prognostic tests improve risk identification but haven't altered current management.
• Genomic and sequencing technologies promise future targeted therapies for high-risk uveal melanoma.